Fabry disease Trials in New York, United States
Conditions / Fabry disease / New York, United States
Fabry disease is a medical condition with active clinical research programs worldwide.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00074971 | A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease | COMPLETED | PHASE3 |
| NCT01031173 | Treatment Protocol of Replagal for Patients With Fabry Disease | NO_LONGER_AVAILABLE | — |
| NCT00925301 | Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease | COMPLETED | PHASE3 |
| NCT00074984 | A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease | COMPLETED | PHASE4 |
| NCT00196742 | Fabry Disease Registry & Pregnancy Sub-registry | RECRUITING | — |
| NCT04046224 | Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) | COMPLETED | — |
| NCT00196742 | Fabry Disease Registry & Pregnancy Sub-registry | RECRUITING | — |
| NCT00081497 | A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease | COMPLETED | PHASE4 |
| NCT01458119 | Open-Label Phase 3 Long-Term Safety Study of Migalastat | TERMINATED | PHASE3 |
| NCT02194985 | Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease | COMPLETED | PHASE3 |